Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2
Xiaoyu Sun, Chenli Qiu(Shanghai Public Health Clinical Center), Jianqing Xu(Weifang Medical University), Qiang Deng(Kunming University of Science and Technology), Hongzhou Lu(Fudan University), Zhuo Yang(Dalian Medical University), Gaowei Hu(Shanghai Medical College of Fudan University), Longfei Ding(Shanghai Public Health Clinical Center), Weihui Fu, Zhiyang Ling(Center for Excellence in Molecular Cell Science), Yadong Fu(Shanghai University of Traditional Chinese Medicine), Xingchen Chen(Harbin Institute of Technology), Shuai Xia(Shanghai Medical College of Fudan University), Yuanfei Zhu(Shanghai Medical College of Fudan University), Shuangfeng Chen(Chinese Academy of Sciences), Yonghui He(Center for Excellence in Molecular Cell Science), Renhong Yan(Southern University of Science and Technology), Aidong Qu(Shanghai FRP Research Institute (China)), Shujuan Du(Shanghai Medical College of Fudan University), Xiaoxia Lü(Sun Yat-sen University), Xiaoyan Zhang(Fujian Medical University), Lu Lu(Shanghai Medical College of Fudan University), Youhua Xie(Shanghai Medical College of Fudan University), Tianlong Zhang(Hangzhou Normal University), Qiang Zhou(Westlake University), Xiuling Li(Dalian Institute of Chemical Physics), Chenjian Gu(Washington University in St. Louis), Yaguang Zhang(Sichuan University), Mu Liu(Shanghai Medical College of Fudan University), Chen Zhao(Jiangsu Province Hospital), Songhua Yuan(Shanghai Medical College of Fudan University), Gary Wong(Ministry of Health), Xu Zhou, Jianping Ding(Center for Excellence in Molecular Cell Science), Chunyan Yi(Institute of Plant Protection), Liyan Ma(Chinese Academy of Sciences), Wangpeng Gu(Center for Excellence in Molecular Cell Science)
Cited by 159
Related Papers
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759